← Eichor
Study identifier: NCT03528226 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Exercise Training and Endothelial Function in Type 1 Diabetes

Condition: Type1diabetes  ·  Sponsor: University Hospital, Lille

PhaseNA
Planned participants34
Who can joinAll sexes, 18 Years to 50 Years
Healthy volunteersNo

About this study

Endothelial dysfunction and vasoreactivity disorders are early subclinical complications of type 1 diabetes (T1D). In a preventive setting, in T1D patients still free of complications, the research of non-pharmacological interventions to improve endothelial function appears fundamental. In this randomized controlled trial, the effects of exercise training on endothelial function will be evaluated in T1D adults. Secondary objectives are to evaluate the exercise training effects on the micro and macrovascular function and exercise-induced tissue vasoreactivity and their possible neurometabolic consequences. An improvement in vascular function, particularly endothelium-dependent, as well as in neurometabolic profile, through this non-pharmacological strategy is expected

This description comes directly from the study's public registry record.

Talk to the study team

Anne Vambergue, MD,PhD  ·  320444184  ·  anne.vambergue@chu-lille.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Hop Claude Huriez Chu LilleLille, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03528226